ArticleNeoplasia (New York, N.Y.)2013

Cellular immunotherapy for carcinoma using genetically modified EGFR-specific T lymphocytes.

Xikun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.